Ebola two-vaccine regimen: Safe, immune response induced in early trials
by Press Release from Outbreak News Today on (#1B7X3)
An immunization regimen using two Ebola vaccine candidates was safe and well-tolerated and induced an immune response in healthy adult volunteers in a Phase 1 clinical trial. Results from the study are described in the April 19th issue of the Journal of the American Medical Association. The National Institute of Allergy and Infectious Diseases (NIAID), ["]
